Cytori plans to start consulting on pharmaceutical affairs strategies with the Pharmaceuticals and Medical Devices Agency (PMDA), aiming for early approval of Nitric Oxide Nasal Spray (“NONS™”), a preventive and therapeutic drug for COVID-19 infection.
